dr. reddy's lab (Emkay) Long term outlook intact; Maintain Accumulate

Q4FY11 revenues grew 29% led by growth across business segments; Going forward, growth will come from North American markets;
Date Rating Target Price Recommendation Price Broker house
13 May 2011 accumulate 1750 1655 Emkay Report

No comments:

Post a Comment